Carlos Villena-Heinsen Selected Research

Chemoprevention

1/2002

Analysis of vitamin D-receptor (VDR) and retinoid X-receptor alpha in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos Villena-Heinsen Research Topics

Disease

3	Carcinoma (Carcinomatosis) 07/2002 - 01/2002
3	Neoplasms (Cancer) 05/2002 - 01/2002
2	Breast Neoplasms (Breast Cancer) 05/2002 - 01/2002
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2002 - 01/2002
1	Seminoma 05/2002
1	Colonic Neoplasms (Colon Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

5	Vitamin D FDA LinkGeneric 07/2002 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 05/2002 - 01/2002
3	Calcitriol Receptors (Calcitriol Receptor)IBA 05/2002 - 01/2002
2	Progesterone Receptors (Progesterone Receptor)IBA 07/2002 - 05/2002
2	Messenger RNA (mRNA)IBA 01/2002 - 01/2002
2	RNA (Ribonucleic Acid)IBA 01/2002 - 01/2002
1	Estrogens (Estrogen)FDA Link 07/2002
1	TESIBA 05/2002
1	AntibodiesIBA 05/2002
1	AntigensIBA 05/2002
1	Estrogen ReceptorsIBA 05/2002
1	RetinoidsIBA 01/2002
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2002
1	Hormones (Hormone)IBA 01/2002
1	hydroxide ionIBA 01/2002
1	Retinoid X Receptor alphaIBA 01/2002
1	Calcifediol (Calcidiol)FDA Link 01/2002

Therapy/Procedure

1	Therapeutics 01/2002
1	Chemoprevention 01/2002